Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Lotus Bio-Technology Development (OTCPK:LBTD) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Lotus Bio-Technology Development's Enterprise Value for the quarter that ended in Dec. 2017 was $15.61 Mil.
Lotus Bio-Technology Development's EBIT for the trailing twelve months (TTM) ended in Dec. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.01 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lotus Bio-Technology Development EV-to-EBIT Related Terms
Lotus Bio-Technology Development EV-to-EBIT Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Agricultural Inputs subindustry, Lotus Bio-Technology Development's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lotus Bio-Technology Development EV-to-EBIT vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, Lotus Bio-Technology Development's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Lotus Bio-Technology Development's EV-to-EBIT falls into.
Lotus Bio-Technology Development's current Enterprise Value is $0.00 Mil.
Lotus Bio-Technology Development's EBIT for the trailing twelve months (TTM) ended in Dec. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.01 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lotus Bio-Technology Development (LBTD) has a EV-to-EBIT of 0.00 as of Aug. 11, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Lotus Bio-Technology Development and its competitors.
Is Lotus Bio-Technology Development's EV-to-EBIT too high?
Lotus Bio-Technology Development's current EV-to-EBIT is 0.00.
How does Lotus Bio-Technology Development's EV-to-EBIT compare to SNES and CVAT?
Lotus Bio-Technology Development's EV-to-EBIT of 0.00 can be compared against companies in the Agriculture industry. The industry median EV-to-EBIT is 12.27. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for an Agriculture company?
The median EV-to-EBIT among Agriculture companies is 12.27, based on 206 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Lotus Bio-Technology Development and its competitors. For the Agriculture industry, the median EV-to-EBIT is 12.27 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Lotus Bio-Technology Development's current EV-to-EBIT is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lotus Bio-Technology Development stock overvalued right now?
Lotus Bio-Technology Development (LBTD) has a current EV-to-EBIT of 0.00. The current EV-to-EBIT is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Lotus Bio-Technology Development (LBTD), the current EV-to-EBIT is 0.00 as of Aug. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LBTD has been successfully added to your 
